HBA1C Study in Diabetic Patients

This study evaluates the role of Hemoglobin A1c (HbA1c) as a glycemic control marker in a diverse cohort of 60 diabetic patients. The sample includes individuals with multiple risk profiles and complications, specifically: obese patients, pregnant women, cardiac patients, and individuals with comorbidities such as retinopathy, nephropathy, neuropathy, and glaucoma. Data were collected through clinical assessments, patient histories, and laboratory investigations. The primary objective was to correlate HbA1c levels with the severity and presence of these complications to assess its reliability as a predictive biomarker. Preliminary analysis shows elevated HbA1c levels were significantly associated with microvascular complications like retinopathy, nephropathy, and neuropathy, as well as with the presence of comorbid conditions. The study underscores the utility of HbA1c not only for routine monitoring but also for risk stratification in diabetic patients with complex clinical backgrounds. Tailored glycemic targets may be necessary for special populations, such as pregnant women and those with cardiac disease or glaucoma.